122 results
424B3
HOTH
Hoth Therapeutics Inc
22 Apr 24
Prospectus supplement
4:15pm
million, respectively. There can be no assurance that the products under development by us will be approved for sale in the U.S. or elsewhere … . Furthermore, there can be no assurance that if such products are approved they will be successfully commercialized, and the extent of our future losses
8-K
EX-10.1
ofg2j zo7s3n
15 Sep 23
Hoth Therapeutics Announces $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:15pm
424B5
g0hldxiv
14 Sep 23
Prospectus supplement for primary offering
5:24pm